“Quatrefolic^® 360°” and the elderly: challenges and opportunities

Aging population and folate levels

In 2050, the over 60 years will represent 22% of the world’s population. As aging comes with new challenges for us bodies, this reality implies an increase in health needs. Studies show that approximately 30% of individuals aged ≥ 65 years old experience a deficiency of folate. Poor folate levels are associated with an increased risk of chronic diseases which may imply hyperhomocysteinemia, significant risks for atherosclerotic vascular disease, and for cognitive dysfunction.

Quatrefolic® and folate restoration in the elderly

Quatrefolic^® effectively supports cardiovascular and nervous system function, including postmenopausal women, and allows the full enjoyment of the golden years. The approved EFSA claims are related to psychological functions, reduction of tiredness and fatigue, cell division, normal homocysteine metabolism, and well function of the immune system, Quatrefolic^® may be a valid nutritional support for people with alterations in the metabolism of folate and, consequently, of homocysteine. In these individuals, the most prevalent polymorphism of the enzyme methylenetetrahydrofolate reductase (MTHFR), may impair the multi-step process of conversion typical of folic acid and food folate, affecting the availability of 5-MTHF.